[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100130594":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":20,"locations":20,"responsibleParty":25,"collaborators":20,"id":27,"slug":28,"hasResults":29,"nctId":30,"briefTitle":31,"officialTitle":32,"acronym":20,"eligibilityCriteria":33,"healthyVolunteers":29,"sex":34,"minAge":35,"maxAge":36,"enrollmentInfo":37,"targetDuration":20,"studyType":40,"phases":41,"briefSummary":43,"conditions":44,"keywords":47,"overallStatus":51,"whyStopped":20,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":20},{"fullName":5,"class":6},"Shanghai Jiao Tong University School of Medicine","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"no home monitoring","NO_INTERVENTION","no automated measuring devices for patients use at home",[13],"Device: Home monitoring",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Home monitoring","automated measuring devices for patients using at home",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Jiguang Wang, Doctor","PRINCIPAL_INVESTIGATOR",{"type":20,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":26,"oldOrganization":26},"Shanghai Institute of Hypertension","100130594","home-monitoring-in-the-management-of-hypertension-and-diabetes-mellitus-100130594",false,"NCT00968786","Home Monitoring in the Management of Hypertension and Diabetes Mellitus","A Trial of the Use of Multiple Automated Measuring Devices in the Management of Patients With Hypertension and Type 2 Diabetes Mellitus","Inclusion Criteria:\n\n* Regardless of whether they are currently receiving antihypertensive therapy, systolic blood pressure higher than 140 mmHg or diastolic blood pressure higher than 90 mmHg.\n* Whether or not use oral hypoglycemic agents or insulin injections, the fasting plasma is higher than 7.0 mmol\u002FL, or postprandial blood glucose higher than 11.1 mmol\u002FL.\n\nExclusion Criteria:\n\n* With life-threatening disease.\n* With the various effects of metabolic diseases such as hyperthyroidism, hypothyroidism, etc.\n* Stroke, myocardial infarction and other serious cardiovascular and cerebrovascular diseases occurred within 3 months.\n* Serum creatinine level higher than 176.8 mmol\u002FL\n* Dementia or severe cognitive decline\n* Unable to do a long-term follow-up or do not agree to participate in this trial.","ALL","18 Years","70 Years",{"count":38,"type":39},100,"ESTIMATED","INTERVENTIONAL",[42],"NA","The home monitoring of automated measuring devices may improve the management of the chronic diseases, and may decrease the incidence of fatal disease. The investigators conducted a small sample and short observation time research to explore the feasibility to carry out later large-scale research.",[45,46],"Hypertension","Type 2 Diabetes Mellitus",[48,49,50],"hypertension","type 2 diabetes","home monitoring","UNKNOWN","2009-08-28",{"date":54,"type":39},"2009-08-31",{"date":56,"type":20},"2008-08",{"date":58,"type":39},"2009-09",{"name":5,"class":6}]